MétaCan
Menu
Back to cohort
Record W2528459578

Selective killing of RAD54B-deficient colorectal cancer cells through SOD1 inhibition

2013· article· en· W2528459578 on OpenAlexaff
Kirk J McManus Babu V Sajesh, Zelda Lichtensztejn

Bibliographic record

VenueJournal of Stem Cell Research & Therapy · 2013
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsUniversity of Manitoba
Fundersnot available
KeywordsSynthetic lethalityCancer researchColorectal cancerBiologyProstate cancerSOD1CancerDNA repairDNA damageCancer cellCell cycleGeneticsDNAGeneMutant
DOInot available

Abstract

fetched live from OpenAlex

C cancer (CRC) affects both males and females, and is the second leading cause of cancer-related deaths in North America. Novel insight into the disease is highly warranted so that new therapeutic approaches can be developed. Synthetic lethality refers to the lethal combination of 2 independently viable mutations and has been extensively studied in model organisms such as yeast. Recently, synthetic lethality has been applied in cancer contexts and is beginning to show potential as a new therapeutic modality. RAD54B is an excellent candidate for therapeutic targeting as it is mutated in CRC and numerous other tumor types. RAD54B is an evolutionarily conserved protein that functions in DNA repair and is essential for chromosome stability. RAD54B deficiencies cause chromosome instability, which we believe can be targeted through a synthetic lethal approach. Utilizing cross-species approaches, 80 candidate synthetic lethal interactors of RAD54B were subjected to an RNAi-based highcontent screen in human cells. Subsequent direct tests validated an interaction between RAD54B and superoxide dismutase 1 (SOD1) in both CRC cells and immortalized fibroblasts. Real-time cell analyses showed that chemical inhibitors are able to selectively kill RAD54B-deficient cells and demonstrated the decreases in cell numbers observed is due to cellular cytotoxicity rather than cell cycle arrest. Thus, we have identified and validated SOD1 as a novel candidate therapeutic target for the treatment of RAD54B-deficient CRCs cells. These data have far reaching implications as RAD54B defects have been identified in numerous tumor types including, prostate, ovarian, bladder and breast. Kirk J. McManus et al., J Stem Cell Res Ther 2013, 3:5 http://dx.doi.org/10.4172/2157-7633.S1.010

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.321
Teacher spread0.288 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Stem Cell Research & TherapySame topicCancer Genomics and DiagnosticsFrench-language works237,207